This study elucidated the processes of protein instability and aggregation, establishing a basis for the investigation of therapeutic agents that may stabilize SOD1 mutants or prevent and/or decrease protein aggregate formation related to ALS disease. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.